Navigation Links
New target to stop cancer's spread discovered by Georgia State scientists
Date:1/30/2013

Disrupting a key interaction between two types of proteins in cells inhibits the spread of cancerous cells, providing researchers with a new pathway toward developing cancer-fighting drugs, according to new findings by Georgia State University scientists.

Cell migration is essential for the spread of cancerous cells, also known as metastasis, as well as for other diseases. The research team in the labs of Zhi-Ren Liu, professor of biology, and Jenny Yang, professor of biochemistry, studied the interaction of two molecules, p68 RNA helicase and calcium-calmodulin.

Interrupting the interaction between p68 and calcium-calmodulin, which is essential for cell migration, inhibited metastasis.

The findings were recently published in Nature Communications.

"Cancer, at its primary site, will not necessary kill," Liu explained. "Cancer kills by multi-site metastasis. If we are able to disrupt this interaction, we will able to inhibit cancer metastasis. The research indicates that the interaction is absolutely required for all cell migration, and we suspect it may not be limited to cancerous-type cells. It may be a general phenomenon for all cell types."

Calcium-calmodulin is an important protein, acting like a messenger to turn different proteins on and off, said Yang, whose lab focuses on calcium's role in biological processes.

"Calmodulin is a very interesting protein and it interacts with many different systems in response to calcium level changes," she said. "We have demonstrated a new target. There are new ways possible to modulate calcium signaling as a way to treat diseases."

Because cell migration is a common phenomenon that is not only normal, but also related to diseases, there are impacts on treating other diseases, Liu said, from inflammation to neurodegenerative diseases and heart disease.


'/>"/>

Contact: Jeremy Craig
jcraig@gsu.edu
404-413-1357
Georgia State University
Source:Eurekalert

Page: 1

Related medicine news :

1. High Complexity Laboratory Testing Supports New Targeted Therapies for Leukemias and Lymphomas
2. Treatment targeting PI3K may delay resistance to anti-HER2 therapy in breast cancer patients
3. Astrocytes identified as target for new depression therapy
4. LSUHSC research provides new drug target for Her-2 related breast cancer
5. Drug targets hard-to-reach leukemia stem cells responsible for relapses
6. Researchers identify new target for common heart condition
7. Targeting use of acid-suppressants in hospital patients
8. Ovarian cancer stem cell study puts targeted therapies within reach
9. Mayo Clinic researchers find new molecule to target in pancreatic cancer treatment
10. Targeted gene silencing drugs are more than 500 times more effective with new delivery method
11. UGA research offers new targets for stroke treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 10, 2016 , ... Holiday shopping, decorating, parties, family gatherings, ... stimuli that can put a great deal of stress on consumers this and ... gifts, food and festive gatherings can lead to excessive behaviors, which has an ...
(Date:12/10/2016)... ... ... When faced with having to use a toilet away from home an ... and contamination of children when they use public toilets. This inspired her to design ... face. , The patent-pending SANI-POCKET enables a person to use a public toilet in ...
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company is ... As a means of expanding capabilities Flottman has added a G&K Vijuk ... code professional inserts (PIs) and patient package inserts (PPIs) that will marry with ...
(Date:12/9/2016)... ... ... An inventor from Cana, Va., wanted to fulfill the need for a device ... The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. It is also ... a matter of minutes, or even seconds. The SAFETY STRAP FOR AMPUTEES is a ...
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... said an inventor from Winchester, Va. "I thought that if the nebulizer had a ... treatments rather than fearing them." , He developed the patent-pending NEBY to avoid the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)...   Hudes Laser Aesthetica announced their ... Astanza Trinity laser and Astanza Liberty IPL technologies. ... removal, IPL hair removal, pigmented and vascular lesion ... Aesthetica is setting high standards for aesthetic clinics ... to deliver effective, long-lasting results. "Hudes ...
(Date:12/9/2016)... SARASOTA, Fla. , Dec. 9, 2016  Harmar Mobility, LLC ... officer and a member of the Board of Directors. ... ... Mr. ... and development of organizations across a variety of industries. He brings ...
(Date:12/9/2016)... DUBLIN , Dec 9, 2016 Research ... Vaccines Market 2016-2020" report to their offering. ... The global travel vaccines market ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
Breaking Medicine Technology: